Pharmacolog is expanding its product portfolio

Pharmacolog introduces two new product concepts based on its patented DrugLog® technology. WasteLog™ and PrepLog™ are newly developed solutions to specifically address the market for Drug Diversion and the market for drug controls in an integrated environment. The products are currently being developed but are expected to be fully launched in the latter part of 2019.

Pharmacolog is engaged in the development and testing of two new product concepts, WasteLog™ and PrepLog™, both of which are based on the technology available in the current DrugLog® but with newly developed software. WasteLog™ is a system that better manages the workflow that prevails when analyzing the returns of narcotic drugs within Drug Diversion Prevention program and is especially designed for the US market. PrepLog™ is an integrated solution for the control of prepared drugs at hospital pharmacies and wards where information about expected substance and concentration are automatically entered in to the system. The result after the completed measurement is also sent back to the electronic prescription system or patient record. Current DrugLog® will continue to be sold to customers who need a standalone instrument for quality assurance of drug preparations or process control, for example quality control of compounding robots.

Product manager Torbjörn Norberg comments. “The need for rapid drug control systems is steadily increasing. What we noted is that each application area has specific requirements for workflow and integration. Therefore, it is a natural development to adapt our technology based on the respective area-specific requirements to achieve a faster market acceptance. At the bottom, our well-proven DrugLog technology remains the guarantor of fast and reliable measurements.”

For more information contact:

Mats Högberg, CEO

Email: mats.hogberg@pharmacolog.com
Phone: +46
70-546 50 21


About Pharmacolog AB

Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.

Download as PDF